e-learning
resources
Paris 2018
Monday, 17.09.2018
Improving the quality of life of patients with bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Peripheral blood eosinophilia and clinical phenotype in Bronchiectasis
H. Abo-Leyah (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), T. Fardon (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
Source:
International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Session:
Improving the quality of life of patients with bronchiectasis
Session type:
Thematic Poster
Number:
2665
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Abo-Leyah (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), T. Fardon (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom). Peripheral blood eosinophilia and clinical phenotype in Bronchiectasis. 2665
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
A case of peripheral eosinophilia
Source: Virtual Congress 2021 – CCC Airway diseases
Year: 2021
Peripheral blood leukocyte immune responses are distinctly altered in sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
Peripheral blood leucocyte phenotype in IPAH and CTEPH
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Peripheral Blood Eosinophils as Marker of Sputum Eosinophilia and Outocome of COPD Exacerbation
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Eosinophilic pneumonias (EP) among patients with peripheral blood eosinophilia in the material of allergology clinic
Source: Eur Respir J 2007; 30: Suppl. 51, 554s
Year: 2007
Pulmonary eosinophilia
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005
Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet
Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017
Year: 2017
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood
Source: Eur Respir J 2005; 26: Suppl. 49, 625s
Year: 2005
Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001
Treatment of moderate-severe asthma with omalizumab is associated with a decrease in peripheral blood eosinophils
Source: Eur Respir J 2007; 30: Suppl. 51, 353s
Year: 2007
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Role of blood neutrophilia as a biomarker in asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Elevated blood eosinophils in bronchiectasis: A distinct phenotype?
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
FE
NO
and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
Source: Eur Respir J 2016; 47:1562-1564
Year: 2016
Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis
Source: Eur Respir J 2016; 48: 1171-1183
Year: 2016
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept